Three ‘E’ challenges for siRNA drug development

Authors:

Abstract
No abstract available
Funding Information
  • Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park
  • National Key Research and Development Program of China (2021YFA1201000, 2021YFC2302400, 2021YFE0106900)
  • Fundamental Research Funds for the Central Universities (2022CX01013)
  • National Natural Science Foundation of China (32171394)
  • Beijing Nova Program (20220484207)
  • Beijing Institute of Technology

This publication has 82 references indexed in Scilit: